News Industry News Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years October 14, 2015
News Conference News TCT 2015 Debaters Question Need for Further Stent Innovation Todd Neale October 13, 2015
News Conference News TCT 2015 Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis October 12, 2015
News Industry News Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease October 12, 2015
News Conference News TCT 2015 Absorb BVS Matches Xience V in Chinese Patients Todd Neale October 12, 2015
News Conference News TCT 2015 Novel Devices Present New Treatment Options for STEMI Yael L. Maxwell October 11, 2015
News Daily News Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores Todd Neale October 08, 2015
News Industry News Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015 October 07, 2015
News Industry News Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System October 05, 2015
News Industry News Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES™ Coronary Stent System September 23, 2015
News Industry News CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System September 21, 2015
Presentation Aortovascular 2015 Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies Presenter: William A. Gray September 18, 2015
News Conference News ESC 2015 EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS Caitlin E. Cox September 02, 2015
News Conference News ESC 2015 ABSORB Trials Pit BRS Against Second-Generation DES Caitlin E. Cox September 02, 2015
News Industry News Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study September 01, 2015
News Conference News ESC 2015 OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES Caitlin E. Cox August 31, 2015
News Daily News DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk Todd Neale August 31, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015